این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
دوشنبه 24 آذر 1404
Journal of Nanostructures
، جلد ۱۲، شماره ۲، صفحات ۳۴۳-۳۵۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Personalized Approaches to the Use of the Antioxidant Ethoxidol in Patients with Coronary Heart Disease
چکیده انگلیسی مقاله
To develop a personalized approach to the use of ethoxidol in patients with CHD based on the definition of criteria for predicting the cytoprotective properties of this drug when tested in vitro. With the introduction of ethoxidol into a sample with a leukocyte suspension, a significant increase in VIcells by 21% (from 41% to 62%, p < 0.001) was observed, which indicates the presence of a cytoprotective property in this drug. A more detailed analysis of the dynamics of the VIcells index showed two variants of changes in cell viability: in 80% of patients VIcells was increased, on average, by 28% (from 36% to 64%, p < 0.001) and in 20% of patients VI cells was decreased, on average, by 10% (from 68% to 58%, p < 0.05). A number of conditions for the initial state of a patient with CHD were identified for the manifestation of cytoprotective properties in ethoxidol: a proatherogenic cholesterol profile (with a serum cholesterol level above 6.6 mmol/l and a high-density lipoprotein level below 1.6 mmol /l), impaired antioxidant status ( low level of serum catalase activity - less than 5 μcatal/l), signs of mitochondrial dysfunction (increased serum urea levels above 8.3 mmol/l, decreased total blood protein levels below 76 g/l), depletion of the adaptation system function (a decrease in the level of lymphocytes in the blood less than 35% and an increase in the level of neutrophils more than 52%), the normal state of thrombopoiesis (the number of immature platelets is not more than 7%).
کلیدواژههای انگلیسی مقاله
Antioxidants, coronary heart disease, in vitro research, leukocytes, microscopy, Personalized pharmacotherapy
نویسندگان مقاله
Olesya V. Romaschenko |
Belgorod State University, Belgorod, Russia
Michail V. Pokrovsky |
Belgorod State University, Belgorod, Russia
Sergey V. Nadezhdin |
Belgorod State University, Belgorod, Russia
Vadim V. Rumbesht |
Belgorod State University, Belgorod, Russia
Nina I. Zhernakova |
Belgorod State University, Belgorod, Russia
Petr K. Alferov |
Belgorod State University, Belgorod, Russia
Natalia D. Grischenko |
Belgorod State University, Belgorod, Russia
Tatiana V. Gorbach |
Belgorod State University, Belgorod, Russia
Kharkiv Kharkiv |
National Medical University, Kharkiv, Ukraine
Lyudmila V. Statsenko |
Belgorod Regional Clinical Hospital of St. Joasaph, s, Belgorod, Belgorod region, Russia
Vladimir G. Kukes |
First Moscow State Medical University, Moscow, Russia
Alexey V. Sychenko |
Belgorod State University, Belgorod, Russia
نشانی اینترنتی
https://jns.kashanu.ac.ir/article_111614_3796276f2b670dea4a6c6acea6eaa0a1.pdf
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات